Which antiarrhythmic drug to choose after electrical cardioversion: A study on non-valvular atrial fibrillation patients
Author:
Publisher
Public Library of Science (PLoS)
Subject
Multidisciplinary
Reference22 articles.
1. Randomized trial of rhythm or rate control in atrial fibrillation: the Pharmacological Intervention in Atrial Fibrillation Trial (PIAF);SH Hohnloser;Eur Heart J,2001
2. Cardiovascular outcomes in the AFFIRM Trial (Atrial Fibrillation Follow-Up Investigation of Rhythm Management). An assessment of individual antiarrhythmic drug therapies compared with rate control with propensity score-matched analyses;S Saksena;J Am Coll Cardiol,2011
3. Rate control is more cost-effective than rhythm control for patients with persistent atrial fibrillation—results from the RAte Control versus Electrical cardioversion (RACE) study;VE Hagens;Eur Heart J,2004
4. Cardioversion of atrial fibrillation: the use of antiarrhythmic drugs;RJ Schilling;Heart,2010
5. Antiarrhythmics for maintaining sinus rhythm after cardioversion of atrial fibrillation;C Lafuente-Lafuente;Cochrane Database Syst Rev,2007
Cited by 15 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Antiarrhythmic preferences and outcomes post DC cardioversion for atrial fibrillation, an Australian rural perspective;Australian Journal of Rural Health;2024-05-20
2. The outcomes of patients with septic shock treated with propafenone compared to amiodarone for supraventricular arrhythmias are related to end-systolic left atrial volume;European Heart Journal: Acute Cardiovascular Care;2024-02-19
3. Propafenone versus amiodarone for supraventricular arrhythmias in septic shock: a randomised controlled trial;Intensive Care Medicine;2023-09-12
4. Propafenone versus Amiodarone for Supraventricular Arrhythmias in Septic Shock: A Randomised Controlled Trial;2023-05-24
5. Cardiovascular outcomes in patients with atrial fibrillation concomitantly treated with antiarrhythmic drugs and non-vitamin k antagonist oral anticoagulants;Europace;2023-03-31
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3